Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.

Market Cap 4.03TCr 596.34Cr 514.46Cr 472.98Cr 445.19Cr 836.55Cr 56TCr 843.58Cr 5.61TCr 2.18TCr 28TCr 2.24TCr 2.19TCr 96TCr P/E 2026 *
29.6x
P/E 2027 * 24.5x
Enterprise Value 3.52TCr 520.52Cr 449.05Cr 412.85Cr 388.59Cr 730.19Cr 49TCr 736.33Cr 4.89TCr 1.9TCr 24TCr 1.95TCr 1.91TCr 83TCr EV / Sales 2026 *
4.37x
EV / Sales 2027 * 3.76x
Free-Float
61.07%
Yield 2026 *
1.28%
Yield 2027 * 1.54%
Manager TitleAgeSince
Chief Executive Officer 70 07/10/1998
Chief Executive Officer 49 19/01/2022
President - -
Director TitleAgeSince
Director/Board Member 49 18/07/2011
Chairman 70 07/10/1998
Director/Board Member 65 18/07/2011
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 596.34Cr
-0.94%-2.14%+40.54%+148.38% 99TCr
-0.42%-1.80%+53.69%+42.60% 56TCr
-0.56%-1.65%+19.27%+59.57% 39TCr
-0.05%+0.68%+24.66%+16.53% 33TCr
-0.09%+0.06%+26.36%+14.29% 28TCr
-0.05%+1.65%+26.61%+33.32% 28TCr
-0.02%+0.87%-41.49%-48.26% 20TCr
-1.78%+1.16%+17.79%+48.77% 18TCr
-1.40%+3.27%+16.16%+59.08% 16TCr
Average -0.52%+0.41%+20.40%+41.59% 37.46TCr
Weighted average by Cap. -0.59%-0.49%+29.25%+65.83%

Financials

2026 *2027 *
Net sales 804.38Cr 119.03Cr 102.68Cr 94Cr 89Cr 166.97Cr 11TCr 168.37Cr 1.12TCr 435.56Cr 5.51TCr 446.73Cr 437.18Cr 19TCr 953.81Cr 141.14Cr 121.76Cr 111.94Cr 105.37Cr 197.99Cr 13TCr 199.65Cr 1.33TCr 516.48Cr 6.54TCr 529.72Cr 518.4Cr 23TCr
Net income 140.48Cr 21Cr 18Cr 16Cr 16Cr 29Cr 1.96TCr 29Cr 195.39Cr 76Cr 962.81Cr 78Cr 76Cr 3.33TCr 171.18Cr 25Cr 22Cr 20Cr 19Cr 36Cr 2.39TCr 36Cr 238.09Cr 93Cr 1.17TCr 95Cr 93Cr 4.06TCr
Net Debt -512.36Cr -76Cr -65Cr -60Cr -57Cr -106.36Cr -7.16TCr -107.25Cr -712.62Cr -277.44Cr -3.51TCr -284.55Cr -278.47Cr -12TCr -446.21Cr -66Cr -57Cr -52Cr -49Cr -93Cr -6.23TCr -93Cr -620.61Cr -241.62Cr -3.06TCr -247.81Cr -242.52Cr -11TCr
Logo Asymchem Laboratories (Tianjin) Co., Ltd.
Asymchem Laboratories Tianjin Co Ltd is a China-based company mainly engaged in providing one-stop comprehensive services for pharmaceutical outsourcing. The Company's business includes customized research and development and production of small molecule drugs (CDMO), chemical macromolecule CDMO, clinical research services, formulation CDMO, biological macromolecule CDMO, technology output and synthetic biology. The Company's product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-conjugated drugs and messenger RNA. The Company mainly conducts its business in domestic and foreign markets.
Employees
10,617
Trader
Investor
Global
Quality
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!